Recently, Nishida et al. also identified CD26 expression on human osteoclasts (OCs), and demonstrated that humanized IgG1 monoclonal antibody targeting CD26, and huCD26 mAb was administrated for the treatment of multiple myeloma [72]. Here, DPP4 is linked to plasma cell myeloma.